Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo ...

Akebia Therapeutics (AKBA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. As the U.S. market experiences heightened volatility ...

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...

Akebia Therapeutics (NASDAQ:AKBA) announced Thursday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed Xoanacyl as a treatment for high phosphate levels ...

Interested in blogging for timesofindia.com? We will be happy to have you on board as a blogger, if you have the knack for writing. Just drop in a mail at [email protected] with a brief ...

Introduced Trees Are Becoming More Common in the Eastern United States, While Native Diversity Declines Apr. 21, 2025 — In a new study, researchers used more than 5 million measurements from ...

SEC Filings provided by EDGAR Online, Inc.

The latest price target for Akebia Therapeutics (NASDAQ:AKBA) was reported by HC Wainwright & Co. on April 4, 2025. The analyst firm set a price target for $7.50 expecting AKBA to rise to within ...

View the tentative list of planting locations for the upcoming planting season. Plant a tree on your own If you want to plant a tree on your own in front of your property, you'll need a tree planting ...